Fight CRC Blog

GI ASCO Updates

We learned much more about the role of circulating tumor DNA (ctDNA) tests in treating colorectal cancer at this meeting. I’m looking forward to Manju’s insights about that. From my...

Targeted therapy meets immunotherapy: a trial for metastatic KRAS G12C-mutant CRC

In this blog, we take a deep dive into the Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations (NCT06412198) clinical trial...

Fight CRC Names Anjee Davis as CEO, Driving Bold Vision for the Future

Fight Colorectal Cancer (Fight CRC), the nation’s leading advocacy organization for colorectal cancer awareness, research, and policy, is proud to announce the promotion of Anjee Davis to Chief Executive Officer...

Innovation Summit Sparks Action for Advancing Colorectal Cancer Screening

On October 7-9, 2024, Fight Colorectal Cancer co-hosted with the inaugural Innovation Summit with Exact Sciences. This dynamic three-day event brought together public health leaders, advocates, researchers, and healthcare professionals...

Changing Quality Care in Colorectal Cancer

In response to the persistently high nationwide burden of colorectal cancer (CRC), Fight Colorectal Cancer (Fight CRC) has launched the Colorectal Cancer Care Initiative (CRCCI), a vital collaboration aimed at...

Early Career Award to Drive Lynch Syndrome Management

Fight Colorectal Cancer (Fight CRC) is proud to announce that its Genetics and Family History Advisory Council is leading an initiative, alongside nearly 150 patient advocacy organizations, medical societies, and...